Metastatic Anaplastic Thyroid Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08912 | Dabrafenib | A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. |
| DB08911 | Trametinib | A kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 1 | Completed | 1 |
| DB11771 | Tremelimumab | 1 | Completed | 1 |
| DB00945 | Acetylsalicylic acid | 2 | Completed | 1 |
| DB09063 | Ceritinib | 2 | Withdrawn | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |